Patent · US Active

Method of treating cancer using amanitin derivatives

US11926631B2 · kind B2 · utility

0Cited by

4References

4Claims

0Family size

Assignee

Heidelberg Pharma Research GmbH · DE

Inventors

Werner Simon · Seeheim-Jugenheim, DE
Susanne Werner-Simon · Hüffelsheim, DE
Christian Lutz · Kassel, DE
Christoph Müller · Birkenau, DE
Torsten Hechler · Ladenburg, DE
Michael Kulke · Ladenburg, DE

Key dates

Filing date	May 11, 2022
Grant date	Mar 12, 2024
Priority date	—
Expiry date	May 11, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to methods for synthesizing amanitin derivatives having an amino group attached to position 6′ of the central tryptophan moiety. The invention furthermore relates to an amanitin derivative having an amino group attached to position 6′ of the central tryptophan moiety, conjugates of such amanitin derivative, and pharmaceutical compositions comprising such conjugates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.